Report Feature
The future of the cell delivery market looks promising with opportunities in musculoskeletal, dermatology, cardiology, and drug discovery & development applications. The global cell delivery market is expected to grow with a CAGR of 6%-8% from 2020 to 2025. The major drivers for this market are surge in demand for regenerative medicines, rising drug development activity, and increasing prevalence of cancer.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global cell delivery market report, please download the report brochure.
In this market, hospitals & specialty clinics is the largest end user segment of cell delivery. Growth in various segments of the cell delivery market are given below:
The study includes trends and forecast for the global cell delivery market by treatment, application, end user, and region as follows:
By Treatment [Value ($ Million) shipment analysis for 2014 – 2025]:
- Allogeneic
- Autologous
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Musculoskeletal
- Dermatology
- Cardiology
- Drug Discovery & Development
- Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Academic & Research Institutes
- Hospitals & Specialty Clinics
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the cell delivery companies profiled in this report include Medipost, Pharmicell, and Mesoblast.
Within this market, hospitals & specialty clinics will remain the largest end user segment over the forecast period due to increasing cases of cancer and rising prevalance of musculoskeletal disorders.
North America will remain the largest region over the forecast period due to increasing prevalance of cancer, rising research activities related to drug discovery, and presence of advanced healthcare infrastructure in the region.
|
Features of the Global Cell Delivery Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global cell delivery market by treatment (allogeneic and autologous), application (musculoskeletal, dermatology, cardiology, drug discovery & development, and other applications), end user (academic & research institutes and hospitals & specialty clinics), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global cell delivery market? Q.5 What are the business risks and threats to the global cell delivery market? Q.6 What are the emerging trends in this cell delivery market and the reasons behind them? Q.7 What are some changing demands of customers in this cell delivery market? Q.8 What are the new developments in this cell delivery market? Which companies are leading these developments? Q.9 Who are the major players in this cell delivery market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this cell delivery market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global cell delivery market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Academic & Research Institutes and Hospitals & Specialty Clinics) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Cell Delivery Market
4.1 Global Cell Delivery Market by Region
4.2.1 Market by Treatment: Allogeneic and Autologous
4.2.2 Market by Application: Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications
4.2.3 Market by End User: Academic & Research Institutes and Hospitals & Specialty Clinics
4.2.4 The United States Cell Delivery Market
4.2.5 The Canadian Cell Delivery Market
4.2.6 The Mexican Cell Delivery Market
4.3.1 Market by Treatment: Allogeneic and Autologous
4.3.2 Market by Application: Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications
4.3.3 Market by End User: Academic & Research Institutes and Hospitals & Specialty Clinics
4.3.4 The Cell Delivery Market of United Kingdom
4.3.5 The German Cell Delivery Market
4.3.6 The French Cell Delivery Market
4.4.1 Market by Treatment: Allogeneic and Autologous
4.4.2 Market by Application: Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications
4.4.3 Market by End User: Academic & Research Institutes and Hospitals & Specialty Clinics
4.4.4 The Chinese Cell Delivery Market
4.4.5 The Indian Cell Delivery Market
4.4.6 The Japanese Cell Delivery Market
4.5.1 Market by Treatment: Allogeneic and Autologous
4.5.2 Market by Application: Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications
4.5.3 Market by End User: Academic & Research Institutes and Hospitals & Specialty Clinics
4.5.4 Brazilian Cell Delivery Market
7.1.1 Growth Opportunities for the Global Cell Delivery Market by Treatment
7.1.2 Growth Opportunities for the Global Cell Delivery Market by Application
7.1.3 Growth Opportunities for the Global Cell Delivery Market by End User
7.1.4 Growth Opportunities for the Global Cell Delivery Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
